Trim 30-35% into $740-757 with $695 trailing stop; tiered reload on RSI reset, consolidation, or breakout above $770
The analyst debate converges with high conviction on direction (trim) and diverges narrowly on execution (25-33% vs 30-35% vs 40-50% trim, $680 vs $695 vs $705-710 stops). All three analysts agree the setup is asymmetric against longs; the binding question is sizing and stop placement, not whether to act. Risk/reward asymmetry is real: 8% upside to $796 target vs 15-18% downside to $600-625 (conservative) or 28-30% to $525.57 (realistic tail). Technical setup is stretched: RSI 76, price pinned to upper Bollinger at $739.66, MACD at cycle highs 11.80, no golden cross (50 SMA $609.96 below 200 SMA $624.03). Q2 fundamentals deteriorated sharply: FCF margin collapsed from 23% to 3%, capex surged +82% YoY, net debt quadrupled to $68.2B, buybacks at zero. Macro is regime change (first Fed hike since 2023, 96% no-cut pricing). Sentiment at maximum crowding (7.8/10). Underweight, not Sell: PEG 0.7 on 30%+ EPS growth, 28% revenue growth, 81.7% gross margin, 3B DAU moat, Muse validation. Underweight, not Hold: leverage trajectory (debt/equity 25%→43%), FCF collapse, and macro backdrop create asymmetric downside over the 4-8 week horizon. Price target $735.00.
| Position | Action |
|---|---|
| Current price in $740-757 zone | Trim 30-35% of META exposure via three-part scale-out: 1/3 at $750-757, 1/3 on $740 retest, final 1/3 on any push to $757+ |
| Retained core position | Trail closing stop at $695 (between Aggressive Analyst's $680 and Conservative Analyst's $705-710) |
Meta has transitioned from an AI capex risk story to an AI consumer-agent winner, with Muse's App Store dominance validating both the product and the narrative re-rating, supported by elite margins (81.7% gross, 48% EBITDA) and 30%+ ROE trading at just 21.14x forward P/E.
| Indicator | Value | Signal |
|---|---|---|
| close | 736.59 | neutral |
| open | 731.47 | neutral |
| high | 757.27 | neutral |
| low | 730.00 | neutral |
| volume | 27,915,040 | bullish |
| 10_ema | 680.34 | bullish |
| 50_sma | 609.96 | bullish |
| 200_sma | 624.03 | bullish |
| rsi | 76.11 | bearish |
| boll_mid | 632.62 | neutral |
| boll_ub | 739.66 | bearish |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: 3-5 day consolidation above $700 without breaking 10 EMA
Then: Reload additional 25% of trim size
MACD momentum is expanding, not fading — the overbought RSI reading reflects demand overwhelming supply after record volume
EV: +$760–$780 (Wells Fargo target $796) · concedes: RSI at 76.11 indicates short-term overbought condition; A pullback to the 680s (7.5% dip) is possible; Q2 2026 net income down 14% YoY and FCF compressed to $1.7B; Amazon blocking Muse removes one commerce partnership; PayPal partnership barely moved the stock (-0.4%); Bear thesis on Intel CPU angle is dismissed as creative stretch
META is setting up as a distribution top: overbought (RSI 76, upper Bollinger pin), macro tail risk (first Fed hike since 2023, 4% cut probability asymmetry), deteriorating fundamentals (FCF -87% sequentially to $1.7B, FCF margin 3%), accelerating leverage (net debt up 4x to $68.2B), and Muse being blocked by walled gardens — all while the stock has already front-run every catalyst with a 36% vertical move.
EV: -$111 to -$136 per share (from $736 to $600-$625, -15% to -18% over 4-8 weeks) · concedes: META was a compelling buy at $543 in mid-August — the bull identified the right narrative at the right time; Muse is a legitimate product with meaningful optionality if monetization scales; The AI arms race capex could eventually pay off if revenue conversion materializes; Zuckerberg's commitment to AI infrastructure is real and could create durable competitive moat; 50 SMA below 200 SMA could resolve bullish if Meta Connect delivers blowout results
→ vs conservative: Hold thesis is gambling not investing; stock went from 543 to 757 in 5 weeks and narrative is fully priced; 15-18% downside vs 8% upside is asymmetric risk
→ vs conservative: 50 SMA below 200 SMA means no confirmed golden cross; rally is fragile single-leg momentum trade, not multi-tier confirmed uptrend
→ vs conservative: Q2 FCF margin collapsed from 23% to 3%; FCF machine powering buyback engine is sputtering; headline growth masks earnings quality deterioration
→ vs conservative: Trim into overbought with plan to reload on confirmation is position management, not market timing
→ vs neutral: 5-10% trim is token gesture that doesn't change risk profile; doesn't protect position or provide ammunition for reload
→ vs neutral: Fundamentals not fine; FCF collapsed, capex surged 82%, net debt quadrupled, buybacks zero; wrong line items being examined
→ vs neutral: Forward P/E of 21 not truly 21 on FCF-adjusted basis if capex stays elevated through 2027
| boll_lb | 525.57 | neutral |
| macd | 33.70 | bullish |
| macd_signal | 21.90 | bullish |
| macd_histogram | 11.80 | bullish |
| atr | 26.07 | neutral |
Support: 525.57 · 609.96 · 624.03 · 632.62 · 665.23 · 680.34 · 730 | Resistance: 739.66 · 757.27
META Technical Analysis for 2026-09-22 shows a powerful bullish breakout with price at 736.59, sitting 8.3% above the 10 EMA (680.34), 20.8% above the 50 SMA (609.96), and 18.0% above the 200 SMA (624.03). The MACD line (33.70) is well above the signal line (21.90) with a rising histogram of +11.80, confirming expanding bullish momentum. However, the RSI at 76.11 is overbought above the 70 threshold and the price is essentially riding the upper Bollinger band (739.66), creating short-term exhaustion risk. ATR elevated at 26.07 suggests using wider stops of 2 × ATR (~$52) for position sizing. Key resistance is at 739.66 and 757.27, with immediate support at 730.00 and the 10 EMA at 680.34.
Market Cap
$1.876 trillion
P/E (TTM)
27.75x
Forward P/E
21.14x
PEG Ratio
0.98
P/B
7.18x
Book Value/Share
$102.52
Dividend Yield
0.28%
Beta
1.243
Revenue (TTM)
$228.2B
Q2 2026 Revenue
$60,801M
Gross Margin (TTM)
81.7%
Q2 2026 Gross Margin
81.4%
EBITDA (TTM)
$109.7B
EBITDA (Q2 2026)
$25,895M
Operating Income (Q2 2026)
$18,775M
Operating Margin (Q2 2026)
30.9%
Net Income (TTM)
$68.1B
Net Income (Q2 2026)
$15,848M
Diluted EPS (Q2 2026)
$6.18
Diluted EPS (TTM)
$26.54
Forward EPS Estimate
$34.84
Free Cash Flow (TTM)
$21.55B
FCF (Q2 2026)
$1,746M
Capex (Q2 2026)
$30,116M
R&D (Q2 2026)
$21.66B
SG&A (Q2 2026)
$9.04B
Total Assets
$449.96B
Total Debt
$112.32B
Long-Term Debt (Q2 2026)
$83.7B
Net Debt
$68.20B
Total Equity
$261.22B
Debt/Equity (standard)
0.43x
Current Ratio
2.226
Working Capital
$69.10B
Tangible Book Value
$237.8B
ROE
29.85%
ROA
14.59%
Operating Margin (TTM)
34.8%
Net Margin (TTM)
29.8%
52W High
$770.60
52W Low
$520.26
50-Day Avg
$608.82
200-Day Avg
$624.63
Strengths
Concerns
META is in a heavy AI infrastructure investment phase with Q2 2026 capex surging 82% YoY to $30.1B, compressing free cash flow to just $1.7B for the quarter despite revenue accelerating 28% to $60.8B. The stock is consolidating between the $608 (50-DMA) and $624 (200-DMA) after pulling back from $770, offering a fair entry at 21x forward P/E with 31% expected earnings growth. The core bull case hinges on whether capex peaks by late 2026/early 2027, allowing FCF margins to normalize back toward 30%+ and the stock to re-rate toward $850+. Near-term catalyst is the Q3 2026 earnings print — any signal of capex moderation would be a major positive; sustained capex elevation keeps the stock range-bound $570-$700.
Macro: Hawkish rate regime following Fed's first hike since 2023; Polymarket pricing zero Fed cuts in 2026 at 96% probability. Recession odds collapsing (US 8%, UK 4%, Japan 4%), supporting soft-landing narrative. Nasdaq hit intraday record high 9/22, led by AI names. Crypto markets show elevated speculative risk (BTC >$86K, crypto liquidations >$800M) but overall risk appetite robust. Narrow market breadth flagged as concentration risk in mega-cap AI names.